Media Briefings

Long COVID update

Journalists: Get Email Updates

What are Media Briefings?

Wednesday, September 28, at 2 p.m. ET

Scientists are racing to understand the collection of symptoms that comprise “long COVID”—a set of persistent and sometimes severe health problems linked to prior infection with SARS-CoV-2, the virus that causes COVID-19. At SciLine’s next media briefing, three experts will describe what the latest research has found about the clinical manifestations of and risk factors for developing long COVID, including vulnerabilities for specific demographic groups; the strengths and limitations of peer-reviewed research on this topic—and what reporters should know and be careful about when covering long COVID; and the evolving menu of available medical interventions to treat and possibly prevent long COVID symptoms. Scientists will brief reporters and then take questions on the record. 


I am a professional journalist, and I would like to register for this Media Briefing:

Dr. Bhramar Mukherjee

University of Michigan

Dr. Bhramar Mukherjee is John D. Kalbfleisch Collegiate Professor and chair of biostatistics; professor of epidemiology and global public health at the University of Michigan School of Public Health; She also serves as the associate director for quantitative data sciences at the University of Michigan Rogel Cancer Center. Her research interests include statistical methods for analysis of electronic health records, studies of gene-environment interaction, Bayesian methods, shrinkage estimation, analysis of high dimensional exposure data. She is the founding director of the University of Michigan’s summer institute on Big Data.

Declared interests:


Dr. Christian Sandrock

UC Davis School of Medicine

Christian Sandrock is director of critical care, professor of medicine, and vice chair for quality and safety at the UC Davis Medical Center. His research interests include emerging infectious diseases at the animal and human interface, particularly respiratory infections such as avian influenza, SARS, and other diseases acquired by humans. He has clinical interests in respiratory infections, community-acquired and viral pneumonia, and ICU-acquired infections. Dr. Sandrock is part of the team that launched a post-COVID-19 clinic to help patients dealing with long-term health issues associated with COVID-19.

Declared interests:


Dr. Alexander Truong

Emory University

Dr. Alexander Truong is a pulmonologist and an assistant professor in the Department of Medicine at Emory University. He has worked on long term outcomes in survivors of critical illness and developed two clinical trials in the use of neuromuscular electrostimulation in the prevention of ICU acquired weakness. His current area of interest include long term outcomes in survivors of critical illness, respiratory failure secondary to neuromuscular weakness, and autoimmune mediate inflammatory lung disease. More recently, Dr. Truong with his colleagues started a post-COVID clinic at Emory’s Executive Park campus.

Declared interests: